0.841

0.46% -0.0039

After Hours: .83 -0.011 -1.31%

Adagio Medical Holdings Inc (ADGM)

Overview News Price History Discussions Forecast

Adagio Medical Holdings Inc stock is traded at $0.841, with a volume of 356.87K. It is down -0.46% in the last 24 hours and down -44.67% over the past month. Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.

Previous Close:

$0.8449

Open:

$0.85

24h Volume:

356.87K

Relative Volume:

3.01

Market Cap:

$18.68M

Revenue:

$137.00K

Net Income/Loss:

$-25.08M

P/E Ratio:

-0.5027

EPS:

-1.6729

Net Cash Flow:

$-19.39M

1W Performance:

-2.25%

1M Performance:

-44.67%

6M Performance:

+6.46%

1Y Performance:

-26.87%

1-Day Range:

$0.8002

$0.88

1-Week Range:

$0.8002

$0.9395

52-Week Range:

$0.74

$2.582

Adagio Medical Holdings Inc Stock (ADGM) Company Profile

Name

Adagio Medical Holdings Inc

Sector

Healthcare (1108)

Industry

Medical Devices (143)

Phone

(949) 348-1188

Address

26051 MERIT CIRCLE, LAGUNA HILLS

Employee

Twitter

Next Earnings Date

2026-05-21

Latest SEC Filings

ADGM's Discussions on Twitter

Compare ADGM vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ADGM Adagio Medical Holdings Inc	0.841	18.77M	137.00K	-25.08M	-19.39M	-1.6729
ABT Abbott Laboratories	87.41	152.88B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	316.48	120.18B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	78.60	100.34B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	57.78	84.95B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.78	47.91B	6.30B	1.07B	1.09B	1.8406

Adagio Medical Holdings Inc Stock (ADGM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-14-26	Initiated	Piper Sandler	Overweight
Dec-02-25	Initiated	Lake Street	Buy

Adagio Medical Holdings Inc Stock (ADGM) Latest News

May 22, 2026

Adagio Medical Holdings (ADGM) Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Ongoing Development CostsRevenue Beat Analysis - Newser

May 22, 2026

May 21, 2026

Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia - BioSpace

May 21, 2026

Adagio Files PMA for Breakthrough Ventricular Ablation System - TipRanks

May 21, 2026

Adagio Medical (ADGM) files FDA PMA for vCLAS ventricular tachycardia ablation system - Stock Titan

May 21, 2026

Adagio Medical submits FDA application for VT ablation system By Investing.com - Investing.com Nigeria

May 21, 2026

Adagio Medical submits FDA application for ventricular tachycardia ablation system - Medical Economics

May 21, 2026

Adagio Medical submits premarket approval application to FDA for Vclas® ventricular ablation system - marketscreener.com

May 21, 2026

First purpose-built VT ablation system heads to FDA after 84% shock-free trial - Stock Titan

May 21, 2026

May 17, 2026

Adagio Medical Holdings' US$2.5m Market Cap Fall Books Insider Losses - Sahm

May 17, 2026

May 14, 2026

Adagio Medical Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2026

TradingKey - TradingKey

May 14, 2026

May 13, 2026

Adagio Medical : BofA Securities 2026 Health Care Conference Presentation (9e4df6) - marketscreener.com

May 13, 2026

May 12, 2026

Adagio Medical Holdings Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView

May 12, 2026

Adagio Medical Holdings, Inc. Q1 2026 10-Q Report: Financials, Risk Factors, and Forward-Looking Statements - Minichart

May 12, 2026

Adagio Medical Reports Strong Q1 2026 Results and Breakthrough FULCRUM-VT Trial Data for Ultra-Low Temperature Ablation Technology 1 - Minichart

May 12, 2026

Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress - BioSpace

May 12, 2026

Adagio Medical Holdings, Inc. 1Q 2026: Revenue $5.2M, EPS ($0.31) — 10-Q Summary - TradingView

May 12, 2026

Adagio Medical (NASDAQ: ADGM) Q1 2026 loss, cash burn and going concern warning - Stock Titan

May 12, 2026

May 08, 2026